Registry of patients with diabetes and those at risk of developing it
Polish Registry of Diabetes - PL: Polski Rejestr Diabetologiczny (PolReD)
This study is creating a registry of people with diabetes, those at risk for it, and healthy individuals to see how their health data can help improve care recommendations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Sex | All |
| Sponsor | Medical University of Bialystok Academic / other |
| Locations | 1 site (Bialystok, Podlaskie Voivodeship) |
| Trial ID | NCT04657367 on ClinicalTrials.gov |
What this trial studies
This project aims to create a comprehensive registry of patients diagnosed with diabetes, those at high risk of developing diabetes, and a control group of normoglycemic individuals. Participants will undergo a detailed medical interview and provide biological samples for various omics analyses, which will be evaluated using artificial intelligence algorithms. The findings will lead to new care recommendations tailored for high-risk patients and those already suffering from diabetes. The study will be conducted at the Clinical Research Center of the Medical University of Bialystok.
Who should consider this trial
Good fit: Ideal candidates include patients with diagnosed diabetes, prediabetes, and normoglycemic individuals willing to participate.
Not a fit: Patients with drug addiction, severe psychiatric disorders, or gestational diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved care recommendations and management strategies for patients with diabetes and those at risk.
How similar studies have performed: Other studies have successfully utilized registries and omics data to improve diabetes care, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with diagnosed diabetes (according to the American Diabetes Association criteria) - diabetes group * patients with diagnosed prediabetes (IFG and/or IGT) - prediabetes group * patients with normoglycemia (NFG and NGT) - normoglycemia group * informed consent Exclusion Criteria: * drug addiction * severe psychiatric disorders * patients with gestational diabetes mellitus * patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions
Where this trial is running
Bialystok, Podlaskie Voivodeship
- Clinical Research Centre, Medical University of Bialystok — Bialystok, Podlaskie Voivodeship, Poland (Recruiting)
Study contacts
- Study coordinator: Lukasz Szczerbinski, MD, PhD
- Email: lukasz.szczerbinski@umb.edu.pl
- Phone: +48858318150
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.